Siga Technologies INC Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Siga Technologies INC (SIGA) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of -$37.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-06
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was -$9.40M, a 236.87% decline year-over-year.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $6.87M.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was -$6.28M, a 137.17% decline year-over-year.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was $16.89M, a 66.30% decline year-over-year.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$433.85K, a 108.26% decline from fiscal 2024.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $5.25M, a 89.77% decline from fiscal 2023.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $51.36M.
- Siga Technologies INC cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was -$4.35M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$37.38M 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -$9.40M 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$433.85K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $16.56M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $27.06M 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | $6.87M 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | $5.25M 10-K · filed 2026-03-10 | |||
| 2024-09-30 | -$50.88M 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$43.20M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | -$6.28M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $51.36M 10-K · filed 2026-03-10 | |||
| 2023-09-30 | -$27.68M 10-Q · filed 2024-11-07 | |||
| 2023-06-30 | -$22.58M 10-Q · filed 2024-08-01 | |||
| 2023-03-31 | $16.89M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | -$4.35M 10-K · filed 2025-03-11 | |||
| 2022-09-30 | $6.61M 10-Q · filed 2023-11-07 | |||
| 2022-06-30 | $11.39M 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $50.12M 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$14.75M 10-K · filed 2024-03-12 | |||
| 2021-09-30 | -$25.07M 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | -$19.40M 10-Q · filed 2022-08-04 | |||
| 2021-03-31 | -$11.36M 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | -$43.10M 10-K · filed 2023-03-02 | |||
| 2020-09-30 | -$82.32M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$107.92M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$83.61M 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | -$19.41M 10-K · filed 2022-03-03 | |||
| 2019-09-30 | -$4.17M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | -$4.40M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$56.16K 10-Q · filed 2020-05-06 | |||
| 2018-12-31 | $143.30M 10-K · filed 2021-03-04 | |||
| 2018-09-30 | $70.98M 10-Q · filed 2019-11-05 | |||
| 2018-06-30 | -$13.79M 10-Q · filed 2019-08-06 | |||
| 2018-03-31 | -$8.56M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | -$19.07M 10-K · filed 2020-03-05 | |||
| 2017-09-30 | -$10.54M 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$2.89M 10-Q · filed 2018-08-07 | |||
| 2017-03-31 | -$1.13M 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |